For research use only. Not for therapeutic Use.
Hydroxythiovardenafil is a sulfhydryl-containing analog of vardenafil, a phosphodiesterase type 5 (PDE5) inhibitor used primarily for treating erectile dysfunction. This compound acts similarly by enhancing blood flow to particular body areas. Hydroxythiovardenafil is often encountered as a contaminant or undeclared ingredient in dietary supplements marketed for sexual enhancement.
| Catalog Number | R059318 |
| CAS Number | 912576-30-8 |
| Synonyms | 2-[2-Ethoxy-5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]phenyl]-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazine-4(1H)-thione; 4-[[3-(1,4-Dihydro-5-methyl-7-propyl-4-thioxoimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxyphenyl]sulfonyl]-1-piperazineethano |
| Molecular Formula | C23H32N6O4S2 |
| Purity | ≥95% |
| Storage | RT |
| IUPAC Name | 2-[2-ethoxy-5-[4-(2-hydroxyethyl)piperazin-1-yl]sulfonylphenyl]-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazine-4-thione |
| InChI | InChI=1S/C23H32N6O4S2/c1-4-6-20-24-16(3)21-23(34)25-22(26-29(20)21)18-15-17(7-8-19(18)33-5-2)35(31,32)28-11-9-27(10-12-28)13-14-30/h7-8,15,30H,4-6,9-14H2,1-3H3,(H,25,26,34) |
| InChIKey | GXMTWHWNRQQKJK-UHFFFAOYSA-N |
| SMILES | CCCC1=NC(=C2N1NC(=NC2=S)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CCO)OCC)C |
